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Y-antigen kiliing by Τ cells
of women is restricted by HL Α
CYTOTOXIC Τ cells are important in graft rejection and in the
control of virus infections, but the mode of interaction of these
cells with their targets, particularly in man remains unclear. It
has been shown in mice that products of genes in the major
histocompatibility complex (H-2) are involved in these inter-
actions even when the cytotoxic Τ cells are specific for viral or
non-H-2 antigens. This involvement is seen as the requirements
that the target cell must express the specific non-H-2 antigen
and in addition the same H-2, D or Κ region antigens as were
present on the cells which initiated the immune response1"4.
Cytotoxic Τ cells specific for viral or non-H-2 antigens are thus
restricted in the targets that they can kill by the H-2 antigens
on the targets. For example, cytotoxic Τ cells from H-2 b female
mice suitably primed to the Υ antigen of H-2" males, will only
kill cells from male mice carrying an H-2D region derived from
H-2b(refs5,6).Thisreport istoourknowledgethefirstcleardem-
onstration that a similar restriction occurs in man. We describe a
Situation ih man where cytotoxic reactions specific for non-HLA
antigens can only occur when target cells carry both the HLA-
A2 antigen of the original sensitising cell and the non-HLA
target determinant(s). The strong association with maleness
suggests that one of the specific antigens involved was coded
for by the Υ chromosome.
Our study began with an observation that a female patient
(Reef) who had been suffering from aplastic anaemia rejected a
bone marrow graft from her HLA-identical brother. Before this
rejection, a transient chimaerism of peripheral blood cells
indicated that the graft had initially taken. Rejection was
accompanied by a spontaneous recovery of the patient's bone
marrow haemopoietic function, thus allowing further investiga-
tions. Peripheral blood lymphocytes from the patient were used
as effector cells to measure the level of cytotoxicity against
target cells from the patient's family and an unrelated panel.
The patient's lymphocytes were first restimulated in vitro by
incubating them for 6 d with irradiated stimulator cells from her
HLA identical brother. Cytotoxicity was measured using an
isotope release assay7 with target cells which had been incubated
with phytohaemagglutinin for 3 d and then labelled with
sodium "chromate. Effector cells (70xl0 4 ) and target cells
(1 χ 104) in RPM-1640 plus 20% heat-inactivated human AB
serum were incubated for 4 h in round-bottomed microtitre
plates. Plates were centrifuged for 5 min at 200g and the super-
natant removed and counted in a γ-counter. Each cell combina-
tion was tested in triplicate. After subtraction of background
Table 1 Kiliing pattern of cells from patient Reef. against her own
target cells and those from other family members
Targets HLA compatibility % Kiliing of CML
with patient
Donor
Patient
Sib5
Sib 3
Sib 4
Mother
c?
9
ac*
ac
ac
ad
ad
cd
yes
yes
yes
no
no
no
63f
- 1
63
53
31
4
18t
NT
NT
13
NT
0
Table 1 shows percentage of chromium release of tests in which the
patient's cells were tested against members of her family. NT, not
tested.
*HLA haplotypes: a, A2, BW40, W6, CW3; b, A2, BW40, W6,
CW3; c, A2, B12, W4, —; d, AW31, BW35, W6, CW4.
tResults after in vitro sensitisation to donor.
JResults without previous in vitro sensitisation. MLRs between
donor, patient and sib 5 were sufficiently low to exclude the possi-
bility of a recombination between HLA-B and HLA-D.
Table 2 Positive and negative kiliing by cells from patient Reef
against target cells from unrelated individuals
HLA Phenotypes %
HLA-A HLA-B HLA-C Sex Kill
(Exptl):
week42
Positive control
(donor)
(Expt 2)
weck 52
Positive control
(donor)
(Expt 3)
Week72
Positive control
(donor)
1 1* W31 W35 W40 CW3CW4
11 W15 VßO
2 8 W40
28 W17 W22
5 W21
12.W35
8 W22
— 27
2 2
3 1
4 1
5 9 11
6 2 W31
7 1 2
8 — 11
9 11 W26 W16 W35
10 1 W31 8 W40
2 2 12
11
12
13
14
15
16
17
18
19
20
— CW4 <J
— NT i
— CW1 <J
— CW1 <J
— CW4 2
o
CW1
CW4
CW3
1 2 8 W40
2 3 7 12
3 W30 W35 W40
2 3 7
21 —
7 W40
CW3 <$
— $
NT c?
NT
NT
NT
5
8 W40
5 8
7 12
12 W40
22 11 W31 W15 W17 —
2 2 12 W40 —
$
$
?
CW3 $
CW3 2
— $
o
CW3 $
CW3 2
CW3 <J
23 — 3 18
24 1 9 8 27
25 — 3 W17 18
26 1 2 5 5
27 2 W32 8 W15
28 3 W26 — W35
29 10 28 W35 HR
30 — 9 7 W15
31 1 3 W25 W40 CW2CW4 2
32 1 9 18 W35 — CW4 $
33 1 3 _ W35 CW3 CW4 2
34 1 28 5 8 — — 2
7 W17 — CW3 2
8 W40 — CW3 2
27 CW2CW4 (J
CW1 (J
*
CW4 $
CW3 2
CW4 2
CW4 2
CW3 $
35
36
3 W30
1 9 _
2 2_ 12 W40 — £W3 <J
30
33
28
- 1
0
1
- 3
2
60
44
47
9
4
j
3
15
6
- 1
3
6
- 1
48
-3
0
- 3
2
- 3
1
0
1
- 2
- 1
- 1
- 3
-i
0
13
NT, not tested.
*The HLA antigens compatible with patient Reef are underlined.
the percentage of isotope release was calculated according to
the following formula:
experimental mean—mean
of spontaneous release
freeze-thaw mean (100% release)—mean
of spontaneous release
χ 100 = % kill
In our initial studies performed 31 weeks after grafting, cy-
totoxicity was demonstrated against the donor's lymphocytes
even when the patient's cells had not been restimulated in vitro
(Tabte 1). This suggested that kiliing was to a non-HLA target
as the donor was Η LA identical to his sister. Three further
experiments were performed using effector cells from the
recipient sensitised to the donor and using cells from an un-
related panel as targets. HLA phenotypes are shown in Table 2.
In severa! cases positive reactions were observed. The level of
killing seemed to decline with time, and the gradual waning
seemed to be associated with the patient's recovery. Family
segregation studies were performed on the relatives of
positive panel members. In three such studies the killing pattern
failed to segregate with the HLA haplotype, again confirming
that killing was directed to a non-HLA target or targets
(Table 3).
We have searched for HLA restriction of killing, and a sub-
sequent retrospective analysis revealed a strong association
with HLA-A2. AH targets that were killed carried the HLA-A2
antigen, although not all HLA-A2 cells were killed. The pos-
sibility that a split in HLA-A2 specificities was being recognised
was excluded by the family studies (families 2 and 3, Table 3).
Here the HLA-A2-bearing haplotype was associated with
killing when expressed in one cell, but when expressed on
another cell this haplotype was not associated with killing
(family 2—c haplotype, family 3—a haplotype). Also, in
family 3, no killing was associated with the antigen HLA-A28
which by serology was highly cross-reactive with HLA-A2.
Further analysis revealed that 15 out of 17 targets that were
killed were male. Target cells from all fifteen of the HLA-A2
males were killed (Table 4) but cells from males not carrying
HLA-A2 were not killed. Cells derived from two females were
killed—both females were also HLA-A2 positive, but the level
of killing was at a lower level than that observed with other
positive reactions in the same test. This suggested that at least
two specificities were involved, one associated with the Υ
chromosome exclusively and the other carried by a proportion
of A2 females. One of the females that gave target cells showing
positive killing was a sister of the patient (Table 1). Thepresence
of the second System in the males will have been masked by the
killing specific for the Υ antigen. Α clear example of the inde-
Table 3 Pattern of killing of a non-HLA target by effector cells (raised
between
Family 1
(week 64)
Target
Mother
Father
Cl
C2
C3
Family 2
(week 64)
Mother
Father
Cl
C2
C3
C4
C5
Family 3
(week 72)
Mother
Father
Cl
C2
C3
the patient Reef and her donor) tested on 3
ab
cd
ac
ad
bc
ab
cd
ac
bc
ad
ac
bc
ab
cd
ac
bc
bc
HLA haplotypes
1,8,W6/2,W22,W6
l,8W6/2,W40, W6
3, 7, W6/1, 8, W6
2, 12, W4/2, W40. W6, CW4
2, W40, W6, CW3/28, 12, W4
1,8,W6/2,W35,W6,CW4
i
Sex
$
0
$
<?
3
$
cJ
cj
$
6
VO4
-
?
$
$
6
families
%Kill
0
23
0
19
23
ι
42
34
5
41
1
3
1
13
15
- 1
- 2
In family 2 the female C2 inherited the A2 from the father and was
not killed, but her brother who inherited the same A2 was killed. In
family 3 the male Cl inherited the A2 from the mother and was killed,
but C2 and C3 did not inherit A2 and were not killed. The weeks
represent the time after bone marrow grafting that the family studies
were performed. Compatibility with patient is underlined.
Table 4 Υ chromosome linkage of non-HLA target and restriction of
killing to HLA-A2 positive targets
Sex of HLA-A2 targets
c? $
CML + 15 2*
- 0 17
*LeveI of killing was much lower than other positive targets in
same experiment.
pendent inheritance of an HLA-A2 gene product and the pre-
sumed Υ product was shown in family 3 (Table 3). Here
the HLA-A2 specificity inherited by the male child Cl was from
the mother's a-haplotype. Cells from the two other male
children were not killed.
These results demonstrate that the cell-mediated cytotoxic
reactions of the patient's lymphocytes are specific for non-HLA
antigens but restricted by an HLA product in as much as only
targets carrying HLA-A2 are lysed. This is very similar to the
restriction seen with murine cytotoxic Τ cells reacting with
non-H-2 antigens1 ~~e.
We have not yet unambiguously identified the effector
mechanism in this human cell-mediated cytotoxicity System but
feel it is not an antibody-dependent System as the cytotoxic
reactions occurred in 20% heat-inactivated human AB serum.
In these conditions it has been impossible to measure antibody
dependent cell-mediated cytotoxicity (L. Doyer, personal
communication). This is important as serum from the patient
Reef, when tested against the panel members (Table 2) using
the two-colour fluorescence technique8, gave a positive reaction
with some target cells that were positive in the cytotoxicity test.
Our observations of male-associated killing are analogous to
those of Gordon et al. in the mouse5·6. In their case,
cytotoxicity was only observed after in vivo sensitisation with a
male skin allograft followed by in vitro priming. The clinical
relevance of the Y-associated killing phenomenon is that it is
probably an in vitro reflection of the known inefluence of sex on
the incidence of graft against host disease in bone marrow
transplantation between HLA identical siblings9. In kidney
grafting, several workers have observed that female recipients
of male grafts survived longer than female recipients of female
grafts (ref. 10, and Kissmeyer-Nielsen, Opelz and Terasaki,
personal communication). This was interpreted by Oliver to
indicate that the Y-linked histocompatibility antigen may ac-
tively induce a Prolongation of renal allograft survival in man.
Although these results contrast with our own, they should be
interpreted with caution as HLA-A2 positive combinations were
not separately analysed, and some modes of immunisation to
the Y-linked histocompatibility antigen may result in protective
immunity.
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